These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32565089)

  • 1. Association Between β-Blockers and Outcome of Coronary Artery Bypass Grafting: Before and After 1 Year.
    Park J; Lee SH; Jeong DS; Lee YT; Kim Y; Lee SO; Lee SM; Lee JH; Min JJ; Choi JH; Gwon HC; Carriere K; Ahn J; Kim WS
    Ann Thorac Surg; 2021 Jan; 111(1):69-75. PubMed ID: 32565089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.
    Zhang H; Yuan X; Zhang H; Chen S; Zhao Y; Hua K; Rao C; Wang W; Sun H; Hu S; Zheng Z
    Circulation; 2015 Jun; 131(25):2194-201. PubMed ID: 25908770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of β-blocker therapy for secondary prevention for patients undergoing coronary artery bypass grafting surgery.
    Sun C; Zhang H; Zheng Z
    Curr Opin Cardiol; 2016 Nov; 31(6):654-661. PubMed ID: 27748695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative β-blocker use in coronary artery bypass grafting surgery: national database analysis.
    Brinkman W; Herbert MA; O'Brien S; Filardo G; Prince S; Dewey T; Magee M; Ryan W; Mack M
    JAMA Intern Med; 2014 Aug; 174(8):1320-7. PubMed ID: 24934977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of preoperative beta-blocker use for isolated coronary artery bypass grafting: A systematic review and meta-analysis.
    Wang L; Wang H; Hou X
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):620-629.e1. PubMed ID: 28918203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion.
    Hwang JK; Yang JH; Hwang JW; Jang WJ; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Choi SH
    Medicine (Baltimore); 2016 Jul; 95(30):e4300. PubMed ID: 27472704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?
    Chen J; Radford MJ; Wang Y; Marciniak TA; Krumholz HM
    Arch Intern Med; 2000 Apr; 160(7):947-52. PubMed ID: 10761959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for administering beta-blocker therapy to patients undergoing coronary artery bypass surgery: a systematic review.
    Thaper A; Kulik A
    Expert Opin Drug Saf; 2018 Aug; 17(8):805-813. PubMed ID: 30037300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
    JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America.
    Ferguson TB; Coombs LP; Peterson ED;
    JAMA; 2002 May; 287(17):2221-7. PubMed ID: 11980522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.
    Rocha RV; Tam DY; Karkhanis R; Nedadur R; Fang J; Tu JV; Gaudino M; Royse A; Fremes SE
    Circulation; 2018 Nov; 138(19):2081-2090. PubMed ID: 30474420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy combined with coronary artery bypass grafting in ischaemic heart failure patients: long-term results of the RESCUE study.
    Romanov A; Goscinska-Bis K; Bis J; Chernyavskiy A; Prokhorova D; Syrtseva Y; Shabanov V; Alsov S; Karaskov A; Deja M; Krejca M; Pokushalov E
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):36-41. PubMed ID: 26719401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial.
    Booij HG; Damman K; Warnica JW; Rouleau JL; van Gilst WH; Westenbrink BD
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):277-85. PubMed ID: 26071975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of preoperative β-blocker use and race on long-term survival after coronary artery bypass grafting.
    O'Neal WT; Efird JT; Landrine H; Anderson CA; Davies SW; O'Neal JB; Ferguson TB; Chitwood WR; Kypson AP
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):595-600. PubMed ID: 24139457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term (10-year) outcomes of stenting or bypass surgery for acute coronary syndromes and stable ischemic heart disease with unprotected left main coronary artery disease.
    Park S; Ahn JM; Lee K; Kwon O; Park H; Yoon YH; Kang DY; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    Am Heart J; 2019 Dec; 218():9-19. PubMed ID: 31655415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of multiple chronic total occlusions in coronary arteries according to three therapeutic strategies: Bypass surgery, percutaneous intervention and medication.
    Kim BS; Yang JH; Jang WJ; Song YB; Hahn JY; Choi JH; Kim WS; Lee YT; Gwon HC; Lee SH; Choi SH
    Int J Cardiol; 2015 Oct; 197():2-7. PubMed ID: 26113468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.